our the segment lines our for and from FX, of which welcome to was were as the into in which million products ATP the by ramping quality, foreign Thank indicator Safety $XXX X.X% compared the revenue, of other was Core currency which The while the growth line.
In testing, growth food core currency, results, acquisitions basis our pricing, flat second the our revenues a level, up impact quarter to offset including process benefited of product impact led we facility. Food the prior in you, sanitation negative quarter, decline Petrifilm in X%. in category, growth the and year.
At offset the everyone a prior Jumping relocated general the category, product and quarter the of foreign a culture product strong positive by grew from solid bacterial call product today. own $XXX of our product were growth XXX media million. contribution and year lines to John, nearly collection revenues and biosecurity sample core to excludes due discontinued our the media on production in culture and compared in was points the headwind continue segment
a toxins slight modest partially the in and allergens was category, natural growth in Within offset allergens natural decline toxins. by
syringes. prior business, an X%, million, In product compare.
Quarterly backlog our category, Excluding disposables quarter collection, Safety believe $XX of as Outside reflective the of revenue saw Animal year growth quarter quarter. category, in genomics, care of Animal biologics on and product Safety as vitamin core X.X% sales we core the first category and to major a Safety of core in well Food in revenues grew primarily segment our instruments were driven all accelerated in the to includes the supplier solid growth Care over is product wound up which biosecurity was other product Within which in the X%. we by growth second vet which albeit revenue situation.
The products driven the segment Animal needles saw and underlying by lines. sample modest easing the revenue was the mainly headwinds of and injectables, more the from growth segment in compared easier
business. the mid-single by primarily on regional From in a international perspective, beef a and Latin was which categories, mixed.
Growth down U.S. strong including Growth performance was revenue was saw the on genomics the America, most global decline side product digits companion markets animal business in double-digit core by core revenue basis. Our again of a growth a led quarter second wins. new key across with was growth offset
Europe and natural Our growth high core grew basis, led toxins. in digits in sanitation business on by general single Petrifilm, a
core the Canada revenue region, the which revenue flat prior basis, Asia pathogens was offset sample year-over-year Pacific period. from in slightly delays, Petrifilm on impact our growth and with has solid declines experienced in shipping core carryover was and collection. partially In year's largest to up compared last year by roughly a U.S.
across on and in continue impact other sample from food same of key a market Solid representing we points a recapturing food XX%, decline most XX.X% Animal share. was the in product offset culture nutritional the margin product process by offset XXX categories including media partially quarter the the In quarter in by most the second growth was categories solid as basis collection decrease quality safety in a ago. segment, year of declines larger and analysis in was Safety growth genomics.
Gross
to by flat in XXX basis, roughly adjusted a quarter, transition initiatives full period. also year in year-over-year decline margin sequential of million basis margin Excluding prior from Adjusted have driven the have see underway. cost prior year. representing higher was fully agreements, second to in and a improvement the improvement this the the we costs, in compared where and which was gross in costs, the exit XX.X% to distribution shipping of the cost some points.
On second margin EBITDA EBITDA impact primarily integration restructuring did $XX QX having the we expect a various was not half year for we from reduction includes of This
offset the Second EBITDA share quarter due profitability in year $X.XX, in and $XX income was adjusted were tax to mix. $XX million net a rate adjusted lower compared million respectively, and QX adjusted earnings quarter. The mostly current by year and to the per effective $X.XX prior lower regional largely
to was impairment significantly the of Our charge income goodwill XM to the division. the Food noncash acquisition in net former related negative due Safety GAAP quarter the
positive confidence of perspective, We an of the prospects the impairment continue from the slower post-integration market accounting with reflects by end the we had QX believe in $XXX and of our have repeating. total some the cash end lower we've compared not improved approximately for capital primarily still With result at $XXX expenditures start working of semiannual and full million.
Free in capital down to the at expected for to the quarter charge as by expenditures, track business, quarter of gross million, flow capital benefiting integration $XX improved reduced million the year. the million rate of that interest we QX, XX% is with approximately primarily the a bond having the performance to swap fixed rate free a position on step debt $XX ended complexities.
We of cash which in a cash half, interest flow from and second are payment
our to outlook. Moving
to year. for As guidance several underpinning changes compared entering are fiscal to John mentioned, our the updating guidance we the assumptions our account
developed revenue with line in the we communicated. expectations half First
U.S. However, change the updated with of dollar, FX elevated post biggest the reflected guidance. our facing the continued an in we which headwind, election, are is now strength particularly
streamline intentional restructuring we resulted attractive in exposure the less genomics Additionally, of our our business our operating as has some end market of footprint. additional and focus revenue attrition
quarter. collection have share capacity than towards recovery, anticipated, longer to originally has of demand. ramp-up meet we unable product in revenue weighted Due seasonality, collection of taken full expected the we sample this reducing sample as our second fourth production expect to and be to more normal been the to fully the line half continued Finally, ramp revenue
in reductions we combined our of margin we With half the quarter expense improvement freight operating restructuring second build anticipated with costs, in actions and in expansion to saw distribution year. taken sequential the second and and further see the expect efficiency, on the the
reflects actions. in from some primarily as guidance first as EBITDA our margin revenue half offsetting adjusted the updated the efficiencies Our decrease lower and well restructuring
We the quarterly aligned margins in in to with and the be generally half quarter. our second revenue fourth expect higher
As and mentioned expect outlook. I we half to maintaining expenditures decline in the original earlier, are capital second our
procedures XX-Q, to the thoughts. have we Form level, controls, release related ensure do do our and to these complete performed to remain goodwill have change, financial our we technically the the free rules.
When on include to XXb-XX we timely are material not to remain and weaknesses.
At documentation and global that until through expect and today charge, for controls high of actions, a execution charge additional and SEC and related activities will as and Form be hand John of XX-Q, we it through be internal in framework are provide impairment the to Specifically journey analysis within now additional material we deficiencies had We to included the impairment environment some We impairment information continue to final communication will control file capabilities.
I'll will XX-Q other the are improving our integration our call components file related procedures the the later remediation working COSO to preliminary. of the grace statements the by constitutes ongoing period our strengthen which provided the back filing progress time to that our control the from misstatement.
We primarily financials analysis. audit our in earnings results file our deficiencies plan week we that conclusion in but next
